The immunohistochemistry (IHC) results demonstrated that DYNC1H1, GTPBP4, PRKDC, RBM19, SF3B4, SPATS2 and TAF9 were significantly increased in HCC tumor cells compared to normal hepatocytes (Figures 9, 10). This evidence concerns the gene TAF9 and hepatocellular carcinoma.